glp 1 birth defects Increased Risk of NICU Stays for Babies Born to Mothers Prescribed GLP-1 Medications in the 90 Days Before Pregnancy Study links GLP-1 use to

Tirzepatide is a dual-action medication that targets both GLP-1 and GIP receptors, which is why clinical trials have shown it producing greater average weight loss than semaglutide alone

An observational study involving 300 participants without sleep disorder diagnoses evaluated the relationships between sleep hygiene practices and subjective sleep quality using the PSQI

The Weight Comes Back GLP-1 medications are destined to be forever medications as weight regain happens when the drugs are stopped

Two collagen types dominate: Type I collagen (mature tendon structure) Type III collagen (early repair phase) In rodent studies, BPC-157-treated tendons showed: Increased type I collagen deposition Improved fiber parallel alignment Better biomechanical strength This suggests influence over: TGF- signalling Matrix metalloproteinases (MMPs) Extracellular matrix remodelling enzymes Balanced ECM remodelling prevents disorganized scar tissue